Status:
COMPLETED
Comparative Quantification of MTX and Its Metabolites Post Glucarpidase
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Lymphoma
Acute Lymphatic Leukemia
Eligibility:
All Genders
Brief Summary
Acidification (i.e., addition of hydrochloric acid) of plasma samples from patients who have received Glucarpidase post high-dose MTX treatment is regarded as a necessary preanalytic step to avoid fur...
Detailed Description
Stored plasma samples (paired - acidified and non-acidified) from the specimens collection ('Tumorbiobank') of the Charité Comprehensive Cancer Center will be analysed by HPLC/MS. A total of 136 samp...
Eligibility Criteria
Inclusion
- Treatment with Glucarpidase
Exclusion
- Lacking patient consent
Key Trial Info
Start Date :
July 6 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT05250869
Start Date
July 6 2022
End Date
December 31 2022
Last Update
July 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité - Universitätsmedizin Berlin
Berlin, Germany, 12200